Michaela Liegertová has long been at the intersection of science, education, and new technologies. Originally a cell and molecular biologist, she is one of the prominent voices in the field of meaningful use of artificial intelligence in research and academia. She comes to IBT with the task of helping us better understand AI, setting up its safe and practical use, and showing where it can really save us time or open up new possibilities.
On May 21–22, 2026, the International Advisory Board (IAB) visited the Institute of Biotechnology of the Czech Academy of Sciences. After four years, its members returned to the teams that had been part of the first evaluation and focused on their further development, scientific results, future direction, and working conditions.
An international team of scientists from the Institute of Biotechnology of the Czech Academy of Sciences at the BIOCEV centre, the Faculty of Science at Charles University, and the Malaghan Institute of Medical Research in New Zealand has summarized the current state of knowledge on the horizontal transfer of mitochondria between immune and tumor cells in a newly published article in the prestigious journal Trends in Cancer. ...
The BIOCEV Research Center in Vestec, near Prague, is celebrating its 10th anniversary. Over the years, this joint project of the Czech Academy of Sciences and Charles University has grown into one of the largest biomedical research centers in the Czech Republic. The project’s founders, scientists, and politicians gathered today at a celebratory event to reflect on the achievements of the past decade.
A new publication in the journal Nature Communications shows that mechanical properties of breast carcinoma tissue can be linked to priming anti-cancer immune responses. A key role in the process is played by mitochondria DNA (mtDNA) that is, under certain circumstances, mobilized into the cytosol, presenting a warning signal. ...
On June 9, 2026, Radomír Pánek, President of the Czech Academy of Sciences, visited the Institute of Biotechnology of the Czech Academy of Sciences. The meeting was part of a series of visits to Czech Academy of Sciences institutions aimed at fostering direct dialogue with institute leadership and staff.
Last week, researchers, software developers, domain experts and early-career scientists met in Prague for the Nucleic Acid Structure Annotation & Prediction Hackathon.
The team from the Laboratory of Molecular Pathogenetics, led by Gabriela Pavlínková from the Institute of Biotechnology of the Czech Academy of Sciences at the BIOCEV center, played a significant role in international research, the results of which were published in the prestigious journal Nature Communications. The study provides new insights that contribute to the development of cell therapy for diabetes.
In April, the 4th IBT Student Day took place at the BIOCEV campus. The conference, organized by PhD students of the Institute of Biotechnology of the Czech Academy of Sciences, offered a full-day program of scientific presentations and discussions.
From the Institute of Biotechnology to the U.S. and back. After three years at Emory University in Atlanta, Maroš Huličiak returned to the institute where he once began his career. Thanks to his newly acquired experience, he took on the role of head of the Centre of Molecular Structure. What did he bring back from his time abroad, where does he want to take the CMS, and what is it like to return “home”?
